Measurement of Human Cytochrome P450 Enzyme Induction Based on Mesalazine and Mosapride Citrate Treatments Using a Luminescent Assay |
Kim, Young-Hoon
(Pharmacological Research Division, Toxicological and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug safety)
Bae, Young-Ji (Pharmacological Research Division, Toxicological and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug safety) Kim, Hyung Soo (Pharmacological Research Division, Toxicological and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug safety) Cha, Hey-Jin (Pharmacological Research Division, Toxicological and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug safety) Yun, Jae-Suk (Pharmacological Research Division, Toxicological and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug safety) Shin, Ji-Soon (Pharmacological Research Division, Toxicological and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug safety) Seong, Won-Keun (Pharmacological Research Division, Toxicological and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug safety) Lee, Yong-Moon (College of Pharmacy, Chungbuk National University) Han, Kyoung-Moon (Pharmacological Research Division, Toxicological and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug safety) |
1 | Auld, D. S., Veith, H. and Cali, J. J. (2013) Bioluminescent assays for cytochrome CYP enzymes. Methods Mol. Biol. 987, 1-9. DOI |
2 | Bosetti, A., Sobol, M., Ma, D., Good T., Liu, D. and Cali, J. J. (2005) Bioluminescent cytochrome CYP assays. Pharmacologyonline 3, 9-18. |
3 | Cali, J. J., Ma, D., Sobol, M., Simpson, D. J., Frackman, S., Good, T. D., Daily, W. J. and Liu, D. (2006) Luminogenic cytochrome CYP assays. Expert Opin. Drug Metab. Toxicol. 2, 629-645. DOI |
4 | Cali, J. J., Niles, A., Valley, M. P., O'Brien, M. A., Riss, T. L. and Shultz, J. (2008) Bioluminescent assays for ADMET. Expert Opin. Drug Metab. Toxicol. 4, 103-120. DOI ScienceOn |
5 | Garcia, M. C., Ma, D., Dicioccio, A. T. and Cali, J. (2008) The use of a high-throughput luminescent method to assess CYP3A enzyme induction in cultured rat hepatocytes. In Vitro Cell. Dev. Biol. Anim. 44, 129-134. DOI |
6 | Kim, S. H., Park, Y. S., Kim, J. M., Park, H. J., Lee, M. H., Park, H. K., Kim, Y. J., Cho, S. H., Shaw, L. M. and Kang, J. S. (2012) Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers. Int. J. Clin. Pharmacol. Ther. 50, 524-531. |
7 | Mann, H. J. (2006) Drug-associated disease: cytochrome CYP interactions. Crit. Care Clin. 22, 329-345, vii. DOI |
8 | Ofotokun, I. (2005) Sex differences in the pharmacologic effects of antiretroviral drugs: potential roles of drug transporters and phase 1 and 2 metabolizing enzymes. Top. HIV Med. 13, 79-83. |
9 | Ogu, C. C. and Maxa, J. L. (2000) Drug interactions due to cytochrome CYP. Proc. (Bayl. Univ. Med. Cent.) 13, 421-423. |
10 | Parkinson, A., Mudra, D. R., Johnson, C., Dwyer, A. and Carroll, K. M. (2004). The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome CYP enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol. Appl. Pharmacol. 199, 193-209. DOI |
11 | Wiersma, H., Escher, J. C., Dilger, K., Trenk, D., Benninga, M. A., van Boxtel, C. J. and Taminiau, J. (2004) Pharmacokinetics of mesalazine pellets in children with inflammatory bowel disease. Inflamm. Bowel Dis. 10, 626-631. DOI |
12 | Wrighton, S. A. and Stevens, J. C. (1992) The human hepatic cytochromes CYP involved in drug metabolism. Crit. Rev. Toxicol. 22, 1-21. DOI |
13 | Zanger, U. M. and Schwab, M. (2013) Cytochrome CYP enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther. 138, 103-141. DOI |